The “aviremic” patients tended to have lower levels of MxA expression than the viremic individuals in both infections, though not reaching statistical significance (relative MxA expression: 50±39 and 380±155, for the HIV-1 cohort; 81±23 and 122±50, for the HIV-2 cohort; respectively). The gene discussed is MX1; the disease is infection.